Stocks Telegraph

CDT Stock Price History and Quote Analysis: Insights for Investors

NASDAQ:CDT

Conduit Pharmaceuticals Inc.

$0.14
-0.0044-3.09%
At Close 4:00 PM
Loading...

Stock Price Today

Conduit Pharmaceuticals Inc. (CDT) stock declined over -3.09%, trading at $0.14 on NASDAQ, down from the previous close of $0.14. The stock opened at $0.14, fluctuating between $0.13 and $0.14 in the recent session.

Stock Snapshot

0.1425
Prev. Close
0.14
Open
13.26M
Market Cap
96M
Number of Shares
0.1319
Day Low
0.1423
Day High
-1.73
P/E Ratio
25.55%
Free Float in %
-0.08
EPS (TTM)
N/A
Book Value
N/A
Cash Flow per Share
1.36M
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
Sep 12, 20240.140.140.130.141.33M
Sep 11, 20240.130.140.130.143.4M
Sep 10, 20240.120.140.120.133.29M
Sep 09, 20240.130.130.120.131.71M
Sep 06, 20240.120.130.120.121.48M
Sep 05, 20240.120.130.120.121.96M
Sep 04, 20240.130.130.120.123.11M
Sep 03, 20240.140.140.110.1323.73M
Aug 30, 20240.130.140.120.1217.33M
Aug 29, 20240.140.140.130.133.82M
Aug 28, 20240.150.160.140.142.9M
Aug 27, 20240.160.160.150.151.66M
Aug 26, 20240.170.170.160.161.96M
Aug 23, 20240.170.170.160.162.47M
Aug 22, 20240.160.180.160.175.55M
Aug 21, 20240.160.160.150.162.93M
Aug 20, 20240.140.170.140.165.56M
Aug 19, 20240.150.170.150.165.57M
Aug 16, 20240.150.170.150.167.62M
Aug 15, 20240.150.160.140.1611.39M

Contact Details

San Diego, CA 92134

United States

Website: https://www.conduitpharma.comContact: 760 471 8536

About Company

Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.

Company Information

Employees7
Beta2.087
Sales or RevenueN/A
5Y Sales Change%0%
Fiscal Year EndsN/A
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current Conduit Pharmaceuticals Inc. (CDT) stock price?

Conduit Pharmaceuticals Inc. (NASDAQ: CDT) stock price is $0.14 in the last trading session. During the trading session, CDT stock reached the peak price of $0.14 while $0.13 was the lowest point it dropped to. The percentage change in CDT stock occurred in the recent session was -3.09% while the dollar amount for the price change in CDT stock was -$0.00.

CDT's industry and sector of operation?

The NASDAQ listed CDT is part of Biotechnology industry that operates in the broader Healthcare sector. Conduit Pharmaceuticals Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CDT?

No Data

How CDT did perform over past 52-week?

CDT's closing price is 22.21% higher than its 52-week low of $0.11 where as its distance from 52-week high of $25.00 is -99.45%.

How many employees does CDT have?

Number of CDT employees currently stands at 7.

Link for CDT official website?

Official Website of CDT is: https://www.conduitpharma.com

How do I contact CDT?

CDT could be contacted at phone 760 471 8536 and can also be accessed through its website. CDT operates from 4995 Murphy Canyon Road, San Diego, CA 92134, United States.

How many shares of CDT are traded daily?

CDT stock volume for the day was 1.36M shares. The average number of CDT shares traded daily for last 3 months was 13.08M.

What is the market cap of CDT currently?

The market value of CDT currently stands at $13.26M with its latest stock price at $0.14 and 96M of its shares outstanding.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Log in to gain access to powerful insights powered by AI and Wallstreet analysts.

Login Form

OR
stockstelegraph

Join to access AI-powered insights from top Wall Street analysts.

Signup Form

OR
stockstelegraph

Log in to gain access to powerful insights powered by AI and Wallstreet analysts.

Reset Password Form

stockstelegraph

Subscribe to gain access to powerful insights powered by AI and Wallstreet analysts.

This feature is only available to Premium Users.

Subscribe Now